Esophageal Adenocarcinoma Methods and Protocols

6

ciplinary management team approach in the caring of the patients

and multidisciplinary research on the cancer. It is important for

the researchers to understand the current clinical and pathologi-

cal managements of patients with esophageal adenocarcinoma.

The knowledge of these provide the basic framework and materi-

als for research in this area. In addition, there are many molecular

tools available with preliminary data noted. The chapters in this

book will cover the protocols of all the abovementioned areas in

esophageal adenocarcinoma.

It is likely that these researches could help in understanding

more about the progression of the disease, increased the detection

of sensitive and specific predictive and prognostic maker as well as

finding of new target therapy for patients with esophageal

adenocarcinoma.

References

1. Lam KY, Ma L (1997) Pathology of esophageal
   cancers: local experience and current insights.
   Chin Med J 110:459–


2. Rubenstein JH, Shaheen NJ (2015)
   Epidemiology, diagnosis, and management of
   esophageal adenocarcinoma. Gastroenterology
   149:302–


3. Runge TM, Abrams JA, Shaheen NJ (2015)
   Epidemiology of Barrett’s esophagus and
   esophageal adenocarcinoma. Gastroenterol
   Clin North Am 44: 203–


4. Lagergren J, Lagergren P (2013) Recent
   developments in esophageal adenocarcinoma.
   CA Cancer J Clin 63:232–


5. Butt J, Kandel G (2014) Barrett esophagus:
   when to endoscope. Clin Endosc 47:40–


6. Joo MK, Park JJ, Chun HJ (2018) Additional
   benefits of routine drugs on gastrointestinal
   cancer: statins, metformin, and proton pump
   inhibitors. Dig Dis 36:1–


7. Beales IL, Dearman L, Vardi I, Loke Y (2016)
   Reduced risk of Barrett’s esophagus in statin

users: case-control study and meta-analysis.

Dig Dis Sci 61:238–

8. Gharahkhani P, Fitzgerald RC, Vaughan TL
   et al (2016) Genome-wide association studies
   in esophageal adenocarcinoma and Barrett’s
   esophagus: a large-scale meta-analysis. Lancet
   Oncol 17:1363–


9. Kadota T, Fujii S, Oono Y, Imajoh M, Yano
   T, Kaneko K (2016) Adenocarcinoma aris-
   ing from heterotopic gastric mucosa in
   the cervical esophagus and upper thoracic
   esophagus: two case reports and literature
   review. Expert Rev Gastroenterol Hepatol
   10:405–


10. Ning B, Abdelfatah MM, Othman MO
    (2017) Endoscopic submucosal dissection
    and endoscopic mucosal resection for early
    stage esophageal cancer. Ann Cardiothorac
    Surg 6:88–


11. Barnes JA, Willingham FF (2015) Endoscopic
    management of early esophageal cancer. J Clin
    Gastroenterol 49:638–

Alfred K. Lam